Data temporarily unavailable
Unable to load analysis for « - » for now. Try again in a few moments.

Investlytic score: 3/5 criteria met. Data as of 05/10/2026.
- ✅ Price trend passed
- ✅ Growth passed
- ❌ Debt failed
- ✅ P/E passed
- ❌ Correction failed
Price trend
Overall trend (8 years): the price has been multiplied by at least 1.5.
Price change 2018 → 2019: 35.88%
Price change 2019 → 2020: 11.40%
Price change 2020 → 2021: 17.57%
Price change 2021 → 2022: -7.35%
Price change 2022 → 2023: -3.31%
Price change 2023 → 2024: 14.41%
Price change 2024 → 2025: -14.52%
Price change 2025 → 2026: 1.12%
Price change 2026 (year to date): 2.20%
Financial growth
Revenue CAGR (8 years): 3.66%
Earnings CAGR (8 years): 22.41%
Growth status: positive trend (>1%/yr) in revenue and earnings.
Debt
Debt-to-equity ratio: 0.64
Debt/equity > 0.5 (maximum threshold).
P/E (Price/Earnings)
P/E ratio: 20.88
P/E < 25.0 (maximum threshold).
Correction (6 months)
Current correction: 5.13% from the high over 6 months.
Insufficient correction (< 10.0%).
Criteria of the Investlytic model
- / 5Free with the Investlytic logo. Paste this line into your page: options.
<script src="https://investlytic.co/encart.js" data-symbole="PG" data-lang="en"></script>Price trend
Price & trend
Interactive chart →💰 Dividend
Dividend ranking →⚖️ Comparison with the market
All stocks →| Stock | P/E | Dette/FP | Revenue growth | Rating |
|---|---|---|---|---|
| The Procter & Gamble Company | 24.5 | 0.68 | +0.7 % | 🔒 |
| The Coca-Cola Company | 29.9 | 1.47 | +2.1 % | – |
| Philip Morris International Inc. | 25.5 | – | +2.7 % | – |
| L'Oréal S.A. | 38.1 | 0.34 | +5.6 % | – |
| PepsiCo, Inc. | 17.4 | 2.44 | +3.3 % | – |
Data from the Investlytic screener. The rating of the stock being viewed is reserved for members.
Detailed analysis · Price trend
-
Revenues & profits
Revenue and net income
Financial indicators
Annual financial statements
| Fiscal year | Revenue | Net income | Net margin | EPS | Revenue growth |
|---|
Key reported figures
Revenue, net income and net margin reported by The Procter & Gamble Company over the latest fiscal years.
| Fiscal year | Revenue | Net income | Net margin | Revenue growth |
|---|---|---|---|---|
| 2021 | 76.1 bn | 14.3 bn | 18.8 % | n/a |
| 2022 | 80.2 bn | 14.7 bn | 18.4 % | +5.3 % |
| 2023 | 82.0 bn | 14.7 bn | 17.9 % | +2.3 % |
| 2024 | 84.0 bn | 14.9 bn | 17.7 % | +2.5 % |
| 2025 | 84.3 bn | 16.0 bn | 18.9 % | +0.3 % |
| 2026 | 87.0 bn | 16.0 bn | 18.4 % | +3.3 % |
Amounts converted to USD. Source: published annual accounts, collected on 20/11/2026.
Accounts and financial health
Balance sheet and cash flow published by The Procter & Gamble Company over the last fiscal years, strength scores and valuation by discounted cash flow (DCF).
| Fiscal year | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Cash and investments | 7.2 bn | 8.2 bn | 9.5 bn | 9.6 bn | 9.9 bn |
| Total Debt | 32.3 bn | 35.4 bn | 33.4 bn | 35.5 bn | 35.0 bn |
| Net Debt | 25.1 bn | 27.2 bn | 23.9 bn | 25.9 bn | 25.1 bn |
| Equity | 46.6 bn | 46.8 bn | 50.3 bn | 52.0 bn | 54.3 bn |
| Total assets | 117 bn | 121 bn | 122 bn | 125 bn | 127 bn |
| Operating cash flow | 16.7 bn | 16.8 bn | 19.8 bn | 17.8 bn | 19.6 bn |
| Investments (capex) | 3.2 bn | 3.1 bn | 3.3 bn | 3.8 bn | 4.4 bn |
| Free cash-flow | 13.6 bn | 13.8 bn | 16.5 bn | 14.0 bn | 15.1 bn |
| Share buybacks | 10.0 bn | 7.4 bn | 5.0 bn | 6.5 bn | 5.0 bn |
| Dividends paid | 8.8 bn | 9.0 bn | 9.3 bn | 9.9 bn | 10.2 bn |
Amounts in USD, currency of the published accounts.
Trailing 12-month ratios
Altman Z: default risk estimated from the balance sheet and earnings. Piotroski: 9 tests on profitability, debt and efficiency. DCF: estimated value from discounted future cash flows, a model and not a forecast. Source: annual accounts published by the company, data as of 21/11/2026.
Valuation and competitors
The Procter & Gamble Company compared with its sector on the same exchange and with its main competitors.
Direct competitors
| Company | Market cap (USD) | P/E | Net margin |
|---|---|---|---|
| The Procter & Gamble Company | 394 bn | 24.5 | 18.9 % |
| Unilever PLC UL | 143 bn | 22.1 | 18.8 % |
| Colgate-Palmolive Company CL | 79.2 bn | 26.6 | 10.5 % |
| Reckitt Benckiser Group plc RBGLY | 48.0 bn | 12.8 | 22.4 % |
| Kimberly-Clark Corporation KMB | 36.4 bn | 14.7 | 11.7 % |
| Church & Dwight Co., Inc. CHD | 26.7 bn | 31.7 | 11.9 % |
| The Clorox Company CLX | 13.2 bn | 19.8 | 11.4 % |
| Kenvue Inc. KVUE | 37.1 bn | 16.4 | 9.7 % |
| The Estée Lauder Companies Inc. EL | 40.5 bn | 50.6 | -7.9 % |
| Sector median (NYSE) | 22.6 |
Trailing 12-month P/E. Sector: median of companies in the same sector listed on the same exchange, collected on 11/11/2026. Competitors: comparable companies named by the data provider.
Analyst consensus and forecasts
What the financial analysts covering The Procter & Gamble Company publish: ratings, price targets and earnings forecasts.
Breakdown of ratings
Analysts' average target 172.20 USD, DCF value 207.78 USD, share price 169.80 USD.
Average target over the last 3 months: 172.88 USD (16 targets).
Analyst forecasts
| Fiscal year | Revenue | Net income | Expected EPS (range) | P/E on this EPS | Analysts |
|---|---|---|---|---|---|
| 2026 | 87.1 bn | 16.6 bn | 6.88 (6.84 / 6.90) | 24.7 | 14 |
| 2027 | 89.9 bn | 16.9 bn | 6.98 (6.92 / 7.03) | 24.3 | 13 |
| 2028 | 92.7 bn | 17.5 bn | 7.40 (7.24 / 7.56) | 22.9 | 13 |
Amounts in USD, the reporting currency.
Track record against expectations: reported EPS above consensus 11 times over the last 12 releases.
Rating changes (12 months)
| Date | Firm | Before | After |
|---|---|---|---|
| 26/10/2026 | Piper Sandler | Neutral | Neutral |
| 26/10/2026 | Barclays | Equal Weight | Equal Weight |
| 23/10/2026 | JP Morgan | Overweight | Overweight |
| 23/10/2026 | Evercore ISI Group | Outperform | Outperform |
| 23/10/2026 | RBC Capital | Outperform | Outperform |
Source: ratings and forecasts published by analysts, collected on 21/11/2026. An analyst rating or target is not a guarantee.
Dividends and earnings
The Procter & Gamble Company: dividend history, last distributions, stock splits and earnings releases.
Annual dividend per share (USD), adjusted for splits. Light bar: current year, incomplete. Red bar: lower than the previous year.
Latest ex-dividend dates
| Ex-dividend | Amount | Payment |
|---|---|---|
| 23/10/2026 | 1.09 USD | 16/11/2026 |
| 24/07/2026 | 1.09 USD | 17/08/2026 |
| 24/04/2026 | 1.09 USD | 15/05/2026 |
| 23/01/2026 | 1.06 USD | 17/02/2026 |
| 24/10/2025 | 1.06 USD | 17/11/2025 |
| 18/07/2025 | 1.06 USD | 15/08/2025 |
| 21/04/2025 | 1.06 USD | 15/05/2025 |
| 24/01/2025 | 1.01 USD | 18/02/2025 |
Earnings releases
| Date | Published EPS | Expected EPS | Surprise |
|---|---|---|---|
| 22/10/2026 | 2.00 | 1.88 | +6.4 % |
| 29/07/2026 | 1.43 | 1.41 | +1.4 % |
| 24/04/2026 | 1.59 | 1.56 | +1.9 % |
| 22/01/2026 | 1.88 | 1.86 | +1.1 % |
| 24/10/2025 | 1.99 | 1.90 | +4.7 % |
| 29/07/2025 | 1.48 | 1.42 | +4.2 % |
Stock splits
| Date | Operation |
|---|---|
| 21/06/2004 | split: 2 shares for 1 |
| 22/09/1997 | split: 2 shares for 1 |
| 15/06/1992 | split: 2 shares for 1 |
| 20/11/1989 | split: 2 shares for 1 |
| 22/02/1983 | split: 2 shares for 1 |
| 19/05/1970 | split: 2 shares for 1 |
Factual data: ex-dividend history and earnings calendar, as of 21/11/2026. A past dividend does not guarantee the next one.
Who owns the stock
Free float, institutional investors, large funds, executives and elected officials: declared positions in The Procter & Gamble Company.
Indices: S&P 500 (since 04/03/1957), Dow Jones (since 26/05/1932).
Large funds tracked
| Fund | Shares | Value (USD) | Weight in the fund | Change | Quarter |
|---|---|---|---|---|---|
| Vanguard Group | 237 m | 34.0 bn | 0.5 % | +1.2 % | 2025Q4 |
| State Street | 204 m | 30.0 bn | 0.5 % | +101.9 % | 2026Q2 |
| BlackRock | 190 m | 27.9 bn | 0.4 % | +1.6 % | 2026Q2 |
| Geode Capital Management | 66.5 m | 9.7 bn | 0.5 % | +3.2 % | 2026Q2 |
| Morgan Stanley | 47.2 m | 6.9 bn | 0.4 % | -4.2 % | 2026Q2 |
| Norges Bank | 31.8 m | 4.7 bn | 0.5 % | -2.2 % | 2026Q2 |
| Fidelity | 29.3 m | 4.3 bn | 0.2 % | -4.6 % | 2026Q2 |
| T. Rowe Price | 28.9 m | 4.2 bn | 0.4 % | -9.9 % | 2026Q2 |
Latest insider transactions
| Date | Person | Side | Amount |
|---|---|---|---|
| 12/11/2026 | Abd El Hak Hesham | sale | 379,058 USD |
| 05/11/2026 | Schulten Andre | sale | 5.2 m USD |
| 05/11/2026 | Santos De Azevedo Juliana Monteiro | sale | 907,530 USD |
| 04/11/2026 | Schulten Andre | sale | 5.5 m USD |
| 03/11/2026 | Janzaruk Matthew W. | sale | 1.5 m USD |
| 30/10/2026 | Gama Paul | sale | 477,510 USD |
Elected officials' disclosures
| Date | Official | Side | Amount |
|---|---|---|---|
| 05/11/2026 | David Taylor | sale | $1,001 - $15,000 |
| 23/10/2026 | Maria Elvira Salazar | purchase | $1,001 - $15,000 |
| 08/10/2026 | Pete Sessions | sale | $1,001 - $15,000 |
| 12/10/2026 | David Taylor | sale | $1,001 - $15,000 |
| 25/09/2026 | Ro Khanna | purchase | $1,001 - $15,000 |
Sources: 13F filings (quarter shown), executives' Form 4 filings and US Congress members' disclosures, collected on 21/11/2026. Detailed disclosure obligations mainly apply to companies listed in the United States.
PEA and practical information
Rule applied: the French PEA accepts shares of companies headquartered in the European Union or the European Economic Area and subject to corporate income tax; ADRs and tax-exempt property companies (SIIC) are excluded. The institution holding the PEA confirms eligibility.
Frequently asked questions about The Procter & Gamble Company
What is the The Procter & Gamble Company share price?
Latest recorded price: 169.37 USD on 20/11/2026, for a market cap of 393 bn USD.
What is the revenue of The Procter & Gamble Company?
87.0 bn USD for fiscal year 2026, with net income of 16.0 bn USD (net margin 18.4 %).
Does The Procter & Gamble Company pay a dividend?
Yes. Latest dividend: 1.09 USD per share, ex-dividend on 23/10/2026. Over 12 months: 4.32 USD. Yield on the latest known price: 2.5 %.
When does The Procter & Gamble Company report its next earnings?
The next release is expected on 21/01/2027. EPS expected by analysts: 1.81.
What do analysts say about The Procter & Gamble Company?
Out of 53 analysts: 29 buy or strong buy, 23 hold, 1 sell or strong sell. Average price target: 172.20 USD, i.e. +1.4 % from the share price.
What is the P/E ratio of The Procter & Gamble Company?
Trailing 12-month P/E of 24.4, against 22.6 for the sector median on the same exchange (10-year median: 24.9).
Is The Procter & Gamble Company stock eligible for the French PEA?
No: the company is headquartered outside the European Union and the European Economic Area (ISIN US7427181091).
How many employees does The Procter & Gamble Company have?
108,000 full-time employees according to the latest published profile.
Who runs The Procter & Gamble Company?
Jon R. Moeller is the company's chief executive.
Which large funds own The Procter & Gamble Company?
As of 2026Q2, among the large funds tracked: Vanguard Group, State Street, BlackRock, Geode Capital Management, Morgan Stanley.